Additionally, HIF-1 activity is associated with increased cancer mortality [13], invasion [14, 15], metastasis [15, 16], immune evasion [17], and resistance to therapy [18–20], thus providing a rationale for the therapeutic targeting of these transcription factors in cancer [21, 22]. Here, HIF1A is linked to cancer.